KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConstruction in ProgressConvertible DebtCurrent AssetsCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNotes PayablesOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Exact Sciences (EXAS) Current Assets: 2009-2024

Historic Current Assets for Exact Sciences (EXAS) over the last 16 years, with Dec 2024 value amounting to $1.6 billion.

  • Exact Sciences' Current Assets rose 3.76% to $1.6 billion in Q3 2025 from the same period last year, while for Sep 2025 it was $1.6 billion, marking a year-over-year increase of 3.76%. This contributed to the annual value of $1.6 billion for FY2024, which is 31.57% up from last year.
  • Per Exact Sciences' latest filing, its Current Assets stood at $1.6 billion for FY2024, which was up 31.57% from $1.2 billion recorded in FY2023.
  • Exact Sciences' 5-year Current Assets high stood at $2.2 billion for FY2020, and its period low was $982.3 million during FY2022.
  • For the 3-year period, Exact Sciences' Current Assets averaged around $1.2 billion, with its median value being $1.2 billion (2023).
  • In the last 5 years, Exact Sciences' Current Assets spiked by 296.90% in 2020 and then crashed by 35.13% in 2021.
  • Yearly analysis of 5 years shows Exact Sciences' Current Assets stood at $2.2 billion in 2020, then plummeted by 35.13% to $1.4 billion in 2021, then slumped by 31.13% to $982.3 million in 2022, then increased by 21.59% to $1.2 billion in 2023, then soared by 31.57% to $1.6 billion in 2024.